- Home
- DAWN vs HTHT Comparison
DAWN vs HTHT Comparison
Compare DAWN & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- HTHT
- Stock Information
- Founded
- DAWN 2018
- HTHT 2005
- Country
- DAWN United States
- HTHT China
- Employees
- DAWN N/A
- HTHT N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- HTHT Hotels/Resorts
- Sector
- DAWN Health Care
- HTHT Consumer Discretionary
- Exchange
- DAWN Nasdaq
- HTHT Nasdaq
- Market Cap
- DAWN 1.3B
- HTHT 10.0B
- IPO Year
- DAWN 2021
- HTHT 2010
- Fundamental
- Price
- DAWN $12.79
- HTHT $33.47
- Analyst Decision
- DAWN Strong Buy
- HTHT Strong Buy
- Analyst Count
- DAWN 7
- HTHT 4
- Target Price
- DAWN $36.17
- HTHT $46.75
- AVG Volume (30 Days)
- DAWN 937.9K
- HTHT 2.6M
- Earning Date
- DAWN 10-30-2024
- HTHT 11-26-2024
- Dividend Yield
- DAWN N/A
- HTHT 1.89%
- EPS Growth
- DAWN N/A
- HTHT 16.88
- EPS
- DAWN N/A
- HTHT 1.66
- Revenue
- DAWN $101,953,000.00
- HTHT $3,343,360,178.00
- Revenue This Year
- DAWN N/A
- HTHT $11.11
- Revenue Next Year
- DAWN $36.10
- HTHT $8.36
- P/E Ratio
- DAWN N/A
- HTHT $19.95
- Revenue Growth
- DAWN N/A
- HTHT 17.24
- 52 Week Low
- DAWN $11.94
- HTHT $27.03
- 52 Week High
- DAWN $18.07
- HTHT $42.98
- Technical
- Relative Strength Index (RSI)
- DAWN 39.97
- HTHT 46.30
- Support Level
- DAWN $12.26
- HTHT $32.32
- Resistance Level
- DAWN $12.81
- HTHT $33.96
- Average True Range (ATR)
- DAWN 0.52
- HTHT 0.99
- MACD
- DAWN -0.05
- HTHT 0.08
- Stochastic Oscillator
- DAWN 28.94
- HTHT 24.70
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About HTHT H World Group Limited
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, manachised, and franchised models. The company has two operating segments; legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.